Figure 13 shows the cumulative probability of false-positive recall or biopsy in one nonrandomized study (Ho et al., 2022) using Breast Cancer Surveillance Consortium (BCSC) data comparing annual versus biennial screening with digital breast tomosynthesis or digital mammography among women with extremely dense breasts.

Figure 13Cumulative Probability of False-Positive Recall or Biopsy in One NRSI* Using BCSC Data Comparing Annual Versus Biennial Screening with Digital Breast Tomosynthesis or Digital Mammography, Among Women With Extremely Dense Breasts

Abbreviations: BCSC=Breast Cancer Surveillance Consortium; DBT=digital breast tomosynthesis; DM=digital mammography; NRSI=nonrandomized study of intervention

*

Based on data from Ho et al. (2022)140

From: Chapter 3, Results

Cover of Screening for Breast Cancer: A Comparative Effectiveness Review for the U.S. Preventive Services Task Force
Screening for Breast Cancer: A Comparative Effectiveness Review for the U.S. Preventive Services Task Force [Internet].
Evidence Synthesis, No. 231.
Henderson JT, Webber EM, Weyrich M, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.